About Target ALS
Founded in 2013, Target ALS is a 501(c)(3) medical research foundation breaking down barriers to Amyotrophic Lateral Sclerosis (ALS) research to find effective treatments. We have revolutionized ALS research through our landmark Innovation Ecosystem model, fostering unprecedented collaborations between academia and the pharma and biotech industry, providing no-strings-attached access to critical research tools, and acting as a hub of communication and networking for the worldwide scientific community. Driven by impatient optimism, deliberate disruption, and radical collaboration, Target ALS aims to transform ALS into a manageable disease, realizing a world where Everyone Lives. On rare disease day, the funds we raise directly support Target ALS’ mission to break down barriers to ALS research to find effective treatments. With this support, we can invest in more groundbreaking research and work towards a world where everyone with ALS lives.